Shiqi Ren

702 total citations
34 papers, 480 citations indexed

About

Shiqi Ren is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Shiqi Ren has authored 34 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 9 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Shiqi Ren's work include Ferroptosis and cancer prognosis (13 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Mycorrhizal Fungi and Plant Interactions (4 papers). Shiqi Ren is often cited by papers focused on Ferroptosis and cancer prognosis (13 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Mycorrhizal Fungi and Plant Interactions (4 papers). Shiqi Ren collaborates with scholars based in China, Uzbekistan and United States. Shiqi Ren's co-authors include Ziheng Wang, Chenlin Zhang, Yidan Sun, Bo Zhang, Ran Xu, Qiong Wu, Fei Ju, Wei Wang, Jianfei Huang and Qianqian Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Catalysis and Electrochimica Acta.

In The Last Decade

Shiqi Ren

30 papers receiving 474 citations

Peers

Shiqi Ren
Min Deng China
Stephanie Shao United States
Carolina Meloni Vicente Brazil
Jiayan Fan China
Ana Marı́a Espinosa Mexico
Dmitrii E. Polev Russia
Tania Mesa United States
Jitendra Badhai Sweden
Zsuzsanna Lichner Canada
Min Deng China
Shiqi Ren
Citations per year, relative to Shiqi Ren Shiqi Ren (= 1×) peers Min Deng

Countries citing papers authored by Shiqi Ren

Since Specialization
Citations

This map shows the geographic impact of Shiqi Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiqi Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiqi Ren more than expected).

Fields of papers citing papers by Shiqi Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiqi Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiqi Ren. The network helps show where Shiqi Ren may publish in the future.

Co-authorship network of co-authors of Shiqi Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Shiqi Ren. A scholar is included among the top collaborators of Shiqi Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiqi Ren. Shiqi Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hu, Zhenhua, et al.. (2025). One-pot preparation strategy for anti-freezing, conductive hemicellulose-based deep eutectic gels. International Journal of Biological Macromolecules. 334(Pt 2). 149108–149108.
2.
Chen, Lijun, et al.. (2025). Keystone taxa play a critical role in regulating soil multifunctionality in Eucalyptus plantations. Agriculture Ecosystems & Environment. 396. 109988–109988. 1 indexed citations
3.
Ren, Shiqi, Xinyi Zhou, Zhen Wang, & Kefei Yuan. (2025). Amino acids metabolism: a potential target for cancer treatment. Molecular Cancer. 24(1). 307–307.
4.
5.
Yang, Yang, et al.. (2024). Identification and analysis of prognostic metabolic characteristics in colon adenocarcinoma. Heliyon. 10(6). e27388–e27388. 5 indexed citations
6.
7.
8.
Chen, Yiyan, et al.. (2023). Effect of continuous aerobic exercise on endothelial function: A systematic review and meta-analysis of randomized controlled trials. Frontiers in Physiology. 14. 1043108–1043108. 38 indexed citations
9.
10.
Wang, Wei, Qianqian Wu, Ziheng Wang, et al.. (2021). Development of a Prognostic Model for Ovarian Cancer Patients Based on Novel Immune Microenvironment Related Genes. Frontiers in Oncology. 11. 647273–647273. 7 indexed citations
11.
Wang, Ziheng, Shiqi Ren, Wei Wang, et al.. (2021). SCAMP4 is a novel prognostic marker and correlated with the tumor progression and immune infiltration in glioma. The International Journal of Biochemistry & Cell Biology. 139. 106054–106054. 14 indexed citations
12.
Wang, Ziheng, Shiqi Ren, Wei Wang, et al.. (2020). Prognostic biomarker MITD1 and its correlation with immune infiltrates in hepatocellular carcinoma (HCC). International Immunopharmacology. 81. 106222–106222. 34 indexed citations
13.
Ren, Shiqi, Wei Wang, Chenlin Zhang, et al.. (2020). Development and Validation of a Clinical Prognostic Model Based on Immune-Related Genes Expressed in Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 10. 1496–1496. 17 indexed citations
14.
Sun, Yidan, Ying Zhang, Shiqi Ren, et al.. (2020). Low expression of RGL4 is associated with a poor prognosis and immune infiltration in lung adenocarcinoma patients. International Immunopharmacology. 83. 106454–106454. 21 indexed citations
15.
Zhang, Bo, Qiong Wu, Ran Xu, et al.. (2019). The promising novel biomarkers and candidate small molecule drugs in lower‐grade glioma: Evidence from bioinformatics analysis of high‐throughput data. Journal of Cellular Biochemistry. 120(9). 15106–15118. 17 indexed citations
16.
Wu, Qiong, Bo Zhang, Yidan Sun, et al.. (2019). <p>Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis</p>. OncoTargets and Therapy. Volume 12. 3545–3563. 28 indexed citations
17.
Wu, Qiong, Bo Zhang, Ziheng Wang, et al.. (2019). Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Pathology - Research and Practice. 215(5). 1038–1048. 16 indexed citations
18.
Zhang, Bo, You Zhou, Ziheng Wang, et al.. (2019). Efficacy and safety of CTLA-4 inhibitors combined with PD-1 inhibitors or chemotherapy in patients with advanced melanoma. International Immunopharmacology. 68. 131–136. 16 indexed citations
19.
Wang, Ziheng, Bo Zhang, Chenlin Zhang, et al.. (2019). Effect of region on the Outcome of Patients Receiving PD-1/PD-L1 Inhibitors for Advanced Cancer. International Immunopharmacology. 74. 105709–105709. 14 indexed citations
20.
Chao, Tzu‐Yuan, Shiqi Ren, Susan M. Moore, et al.. (2017). SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies. PLoS neglected tropical diseases. 11(12). e0006133–e0006133. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min Deng Breakdown of academic impact, for papers by Stephanie Shao Breakdown of academic impact, for papers by Carolina Meloni Vicente Breakdown of academic impact, for papers by Jiayan Fan Breakdown of academic impact, for papers by Ana Marı́a Espinosa Breakdown of academic impact, for papers by Dmitrii E. Polev Breakdown of academic impact, for papers by Tania Mesa Breakdown of academic impact, for papers by Jitendra Badhai Breakdown of academic impact, for papers by Zsuzsanna Lichner
Rankless by CCL
2026